We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Develops Framework to Help Reviewers Weigh Benefit/Risk
FDA Develops Framework to Help Reviewers Weigh Benefit/Risk
May 7, 2010
The FDA is developing a decision matrix that will be used to provide its drug reviewers more clarity on how to weigh benefits versus risk in the drug approval process and enhance communications with drugmakers regarding those decisions.